# Erythropoietin in Management of Neonatal Hypoxic Ischemic Encephalopathy

> **NCT03163589** · PHASE3 · UNKNOWN · sponsor: **Assiut University** · enrollment: 40 (estimated)

## Conditions studied

- Hypoxic-Ischemic Encephalopathy

## Interventions

- **DRUG:** Erythropoietin
- **DRUG:** normal saline

## Key facts

- **NCT ID:** NCT03163589
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-12-01
- **Primary completion:** 2019-12-01
- **Final completion:** 2020-06-01
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2017-05-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03163589

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03163589, "Erythropoietin in Management of Neonatal Hypoxic Ischemic Encephalopathy". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03163589. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*